Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

<< Previous

Bullboard Posts

Next >>

Post by RazeKreationson Aug 15, 2022 6:24pm

208 Views

Post# 34897859

Webinar

The webinar on Wednesday morning August 17th should bring an insight into the future for Microbix.
So many things happening at the same time will bring very much interest for learning how the business is proceeding. I expect there will be some very positive news.
Here is a link for those that may have questions can sign up for and be able to participate.
It will also be livestreamed on Adelaide Capital Youtube channel for those that just want to listen
https://www.adcap.ca/weekly-events

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?